NEGRINI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 27.760
AS - Asia 12.522
EU - Europa 8.897
SA - Sud America 1.940
AF - Africa 218
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 14
Totale 51.371
Nazione #
US - Stati Uniti d'America 27.239
SG - Singapore 5.197
CN - Cina 3.662
DE - Germania 1.897
IT - Italia 1.719
BR - Brasile 1.620
UA - Ucraina 1.362
HK - Hong Kong 1.202
TR - Turchia 925
GB - Regno Unito 901
FI - Finlandia 722
VN - Vietnam 657
PL - Polonia 608
SE - Svezia 486
RU - Federazione Russa 384
CA - Canada 238
MX - Messico 235
ID - Indonesia 195
IN - India 183
FR - Francia 176
AR - Argentina 150
NL - Olanda 131
BE - Belgio 111
BD - Bangladesh 97
ZA - Sudafrica 95
ES - Italia 85
JP - Giappone 79
AT - Austria 77
CZ - Repubblica Ceca 67
IQ - Iraq 54
EC - Ecuador 49
LT - Lituania 49
RO - Romania 33
IR - Iran 31
PK - Pakistan 31
UZ - Uzbekistan 31
MA - Marocco 24
CO - Colombia 23
VE - Venezuela 22
CL - Cile 21
AE - Emirati Arabi Uniti 20
JO - Giordania 18
PY - Paraguay 18
IE - Irlanda 16
KE - Kenya 16
KR - Corea 16
AU - Australia 15
IL - Israele 15
SA - Arabia Saudita 15
TN - Tunisia 15
CH - Svizzera 14
UY - Uruguay 14
DZ - Algeria 13
OM - Oman 12
DO - Repubblica Dominicana 11
EG - Egitto 11
MY - Malesia 11
LB - Libano 10
PE - Perù 10
BO - Bolivia 9
GR - Grecia 9
KZ - Kazakistan 9
NG - Nigeria 9
NP - Nepal 9
EU - Europa 8
PH - Filippine 8
AL - Albania 7
LV - Lettonia 7
AZ - Azerbaigian 6
CR - Costa Rica 6
HN - Honduras 6
SN - Senegal 6
TW - Taiwan 6
CI - Costa d'Avorio 5
DK - Danimarca 5
ET - Etiopia 5
PA - Panama 5
RS - Serbia 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
CG - Congo 3
GD - Grenada 3
HU - Ungheria 3
MD - Moldavia 3
SR - Suriname 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
EE - Estonia 2
GH - Ghana 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
Totale 51.329
Città #
Singapore 2.951
Fairfield 2.944
Woodbridge 2.756
Ashburn 2.749
Houston 1.901
Chandler 1.547
Jacksonville 1.503
Beijing 1.234
Hong Kong 1.189
Ann Arbor 1.188
Santa Clara 1.188
Seattle 1.104
Wilmington 1.030
Cambridge 903
Munich 753
Warsaw 593
Izmir 561
New York 546
Los Angeles 489
Nanjing 467
Dallas 443
Ferrara 380
Princeton 346
San Diego 274
Boardman 250
Helsinki 244
Milan 240
Ho Chi Minh City 214
Shanghai 209
São Paulo 173
Mexico City 159
Turku 158
Jakarta 154
Nanchang 140
Shenyang 130
London 129
Tianjin 114
Hanoi 113
Hefei 113
Bremen 110
Brussels 104
Dearborn 103
Brooklyn 100
Buffalo 98
Chicago 94
Montreal 94
Denver 92
Addison 90
Falls Church 87
Dong Ket 81
Changsha 80
Orem 77
The Dalles 76
Poplar 72
Tokyo 72
Hebei 71
Johannesburg 71
Stockholm 69
Jiaxing 68
Moscow 67
Atlanta 66
Bologna 64
Jinan 64
Rome 63
Phoenix 62
Mountain View 61
Toronto 60
Falkenstein 57
Boston 56
Chennai 56
Rio de Janeiro 56
San Mateo 56
Kunming 55
Amsterdam 53
Nuremberg 51
San Francisco 50
Washington 50
Guangzhou 49
Redwood City 48
Manchester 46
Brno 45
Norwalk 45
San Jose 44
Ningbo 43
Zhengzhou 43
Frankfurt am Main 42
Vienna 40
Ankara 39
Columbus 39
Auburn Hills 34
Council Bluffs 33
Hangzhou 33
Augusta 32
Philadelphia 32
Mumbai 31
Tappahannock 29
Verona 29
Querétaro 28
Belo Horizonte 26
Brasília 26
Totale 35.191
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 625
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 363
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 337
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes 311
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 305
Absolute quantification of cell-free microRNAs in cancer patients 280
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 272
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis 270
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 268
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers 267
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 264
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 261
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 256
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 255
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 254
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 250
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 240
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 236
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 236
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 235
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 227
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 226
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 226
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 225
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 224
Multiple loci on human chromosome 11 control tumorigenicity of BK virus transformed cells 222
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 221
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 221
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 220
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 219
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 219
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 217
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 217
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 214
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 211
Circulating non-coding RNA as biomarkers in colorectal cancer 209
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 208
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 208
MicroRNA e cancro 207
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 206
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 206
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 205
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 203
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 203
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 201
BK virus, JC virus and simian virus 40 infection in humans, and association with human tumors 197
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 195
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 194
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 194
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration 194
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 194
RASSF1A QUANTITATIVE METHYLATION-SPECIFIC DROPLET DIGITAL PCR IN URINARY CELLS AS BIOMARKER FOR PROSTATE CANCER DETECTION 193
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 192
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 192
Reprogramming of miRNA networks in cancer and leukemia 191
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 190
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 190
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 190
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 189
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 189
MicroRNA involvement in hepatocellular carcinoma 188
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 188
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 188
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 188
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 188
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 187
Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo 186
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 186
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 186
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 185
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 184
A microRNA signature of hypoxia 183
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 183
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 182
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 181
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 181
Animal Models of Hepatocellular Carcinoma Prevention 179
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 178
Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21 177
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer 175
Abnormal RNA expression of 11p15 imprinted genes and kidney developmental genes in Wilms' tumor 174
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation 174
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 174
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 174
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 173
Analysis of MLH1 promoter methylation in colorectal carcinomas with microsatellite instability 173
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 172
BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. In: POLYOMAVIRUSES AND HUMAN DISEASES 171
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 170
Episomal DNA of a BK virus variant in a human insulinoma 169
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 169
Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27 168
Refined subchromosomal location of 21 expressed sequence tags from unknown genes at region 11p15 168
MicroRNA response to environmental mutagens in liver 168
Non-coding RNAs in the reprogramming of glucose metabolism in cancer 168
Aberrant FHIT transcripts in Merkel cell carcinoma 167
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 166
Extensive modulation of a set of microRNAs in primary glioblastoma 166
Cloning and characterization of two overlapping genes in a subregion at 6q21 involved in replicative senescence and schizophrenia 166
Molecular cytogenetic characterization of marginal zone B-cell lymphoma: correlation with clinicopathologic findings in 14 cases 165
Totale 21.102
Categoria #
all - tutte 238.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9.688
Totale 248.420


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.063 0 0 0 0 0 470 202 510 126 692 701 362
2021/20223.752 139 356 300 169 193 188 217 219 122 271 360 1.218
2022/20233.610 390 233 128 466 604 522 162 301 454 32 189 129
2023/20242.169 187 245 95 58 169 498 112 186 44 42 59 474
2024/20258.797 188 179 650 350 1.005 859 481 499 1.606 794 1.223 963
2025/202612.586 2.253 909 1.871 2.968 3.333 1.252 0 0 0 0 0 0
Totale 51.892